7–8 Jul 2023
Leuven, Belgium
Europe/Brussels timezone

Sponsor talk 2 - Boehringer Ingelheim - Discovery and synthesis of covalent HER2 selective inhibitors for the treatment of HER2 Exon 20 insertion driven tumors

7 Jul 2023, 14:50
20m
MTC1 00.03 (Leuven, Belgium)

MTC1 00.03

Leuven, Belgium

Maria-Theresiacollege Sint-Michielsstraat 6
oral communication Friday

Speaker

Birgit Wilding (Boehringer Ingelheim)

Presentation materials